Top Suppliers:I want be here

13494-90-1

13494-90-1 structure
13494-90-1 structure

Name Gallium(III) nitrate solution
Synonyms gallium(iii) nitrate
gallium nitrate
GALLIUM (III) NITRATE (1:3)
Gallium trinitrate
MFCD00149723
EINECS 236-815-5
Melting Point 110°C (dec.)
Molecular Formula GaN3O9
Molecular Weight 255.738
Exact Mass 254.889038
PSA 206.64000
LogP 0.80900
Appearance Liquid
Water Solubility It is soluble in water.
Name: Gallium(iii) nitrate hydrate 99.9998% Material Safety Data Sheet
Synonym: Gallium nitrate; Gallium trinitrate; Nitric acid, gallium (3+) sal
CAS: 13494-90-1
Section 1 - Chemical Product MSDS Name:Gallium(iii) nitrate hydrate 99.9998% Material Safety Data Sheet
Synonym:Gallium nitrate; Gallium trinitrate; Nitric acid, gallium (3+) sal

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
13494-90-1 Gallium(III) nitrate hydrate 99.9998 236-815-5
Hazard Symbols: XI O
Risk Phrases: 36/38 8

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes and skin. Contact with combustible material may cause fire.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation. May cause conjunctivitis.
Skin:
Causes severe skin irritation.
Ingestion:
May cause burns to the gastrointestinal tract. May cause nausea, vomiting, and diarrhea, possibly with blood.
Inhalation:
Causes respiratory tract irritation. May cause acute pulmonary edema, asphyxia, chemical pneumonitis, and upper airway obstruction caused by edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. Do not use mouth-to-mouth resuscitation if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Strong oxidizer. Contact with other material may cause fire. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water with caution and in flooding amounts. Runoff to sewer may create fire or explosion hazard.
Extinguishing Media:
Use water only! Contact professional fire-fighters immediately. Do NOT use dry chemicals, CO2, Halon or foams.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Cover with sand, dry lime or soda ash and place in a closed container for disposal. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Keep container tightly closed. Avoid contact with clothing and other combustible materials.
Do not get on skin or in eyes. Avoid ingestion and inhalation. Use only in a chemical fume hood. Wash clothing before reuse.
Storage:
Keep away from heat, sparks, and flame. Do not store near combustible materials. Store in a tightly closed container. Store under nitrogen. Store in a cool, dry area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 13494-90-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 110 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 110 deg C
Solubility in water: Soluble.
Specific Gravity/Density: Not available.
Molecular Formula: GaN3O9.xH2O
Molecular Weight: 255.74

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Moisture sensitive.
Conditions to Avoid:
Incompatible materials, ignition sources, dust generation, excess heat, combustible materials, reducing agents.
Incompatibilities with Other Materials:
Strong reducing agents, strong acids, acids, isocyanates, cyanides (e.g. potassium cyanide, sodium cyanide), hypophosphites, moisture, thiocyanates, aluminum powder + water, alkyl esters, phosphinates + heat, heavy metals.
Hazardous Decomposition Products:
Nitrogen oxides.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 13494-90-1: LW9625000 LD50/LC50:
CAS# 13494-90-1: Oral, mouse: LD50 = 4360 mg/kg; Oral, mouse: LD50 = 4400 mg/kg.
Carcinogenicity:
Gallium(III) nitrate hydrate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRATES, INORGANIC, N.O.S.
Hazard Class: 5.1
UN Number: 1477
Packing Group: II
IMO
Shipping Name: NITRATES, INORGANIC, N.O.S.
Hazard Class: 5.1
UN Number: 1477
Packing Group: II
RID/ADR
Shipping Name: NITRATES, INORGANIC, N.O.S.
Hazard Class: 5.1
UN Number: 1477
Packing group: II

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI O
Risk Phrases:
R 36/38 Irritating to eyes and skin.
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 17 Keep away from combustible material.
WGK (Water Danger/Protection)
CAS# 13494-90-1: No information available.
Canada
CAS# 13494-90-1 is listed on Canada's NDSL List.
CAS# 13494-90-1 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13494-90-1 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LW9625000
CAS REGISTRY NUMBER :
13494-90-1
LAST UPDATED :
199701
DATA ITEMS CITED :
12
MOLECULAR FORMULA :
N3-O9.Ga
MOLECULAR WEIGHT :
255.75
WISWESSER LINE NOTATION :
GA N-O3*3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Mammal - species unspecified
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human
DOSE/DURATION :
7 mg/kg
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting Kidney, Ureter, Bladder - renal function tests depressed Kidney, Ureter, Bladder - proteinuria
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human
DOSE/DURATION :
144 mg/kg
TOXIC EFFECTS :
Blood - normocytic anemia Blood - thrombocytopenia
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4360 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - somnolence (general depressed activity) Behavioral - food intake (animal)
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - somnolence (general depressed activity) Behavioral - food intake (animal)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
55 mg/kg
TOXIC EFFECTS :
Behavioral - anorexia (human) Lungs, Thorax, or Respiration - acute pulmonary edema Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg/10D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Lungs, Thorax, or Respiration - pleural effusion Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
750 mg/kg/10D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Related to Chronic Data - death

MUTATION DATA

TYPE OF TEST :
DNA damage
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
40 umol/L
REFERENCE :
JCHODP Journal of Clinical Hematology and Oncology. (Cancer Center at Wadley Institutes, POB 35988, Dallas, TX 75235) V.5(3)- 1975- Volume(issue)/page/year: 7,411,1976
Risk Phrases R8;R36/37/38
Safety Phrases S17;S26;S36/S37/S39
RIDADR UN 1477 5.1/PG 3